Methodological Problems of Assessing the Capital Value of Companies in the Conditions of the Coronavirus Pandemic
Keywords:
capital risk premium, country risk premium, market index, stock, pandemic, stock market, market value, stock valueAbstract
The article examines the methodological problems of assessing companies' capital value in the context of the coronavirus pandemic and describes the scientific and theoretical aspects. Also, the degree of influence of factors influences the assessment of capital value. In particular, the capital risk assessment methodology highlighted, taking into account changes in the country risk premium, country risk premium, and the country's credit default swap spreads. Simultaneously, the coronavirus pandemic on assets in the capital market of Uzbekistan has been studied, and its consequences have been described. The prevalence of COVID-19 infection was also analyzed in the market value of shares of large enterprises traded in RSE "Tashkent". The causes and consequences of the decline in the market value of shares of these enterprises are described. At the same time, scientific and practical recommendations for assessing the capital of companies in a pandemic environment have been developed.
References
1. https://www.weforum.org/agenda/2020/03/stock-market-volatility-coronavirus/
2. Nguyen, Khoa Huu, A Coronavirus Outbreak and Sector Stock Returns: The Tale from The First Ten Weeks of 2020 (March 25, 2020). Available at SSRN: https://ssrn.com/abstract=3559907 or http://dx.doi.org/10.2139/ssrn.3559907
3. Decree of the President of the Republic of Uzbekistan "On priority measures to mitigate the negative impact of the coronavirus pandemic and global crisis on economic sectors". No. PF-5969, March 3, 2020.
4. https://www.investopedia.com/s-and-p-500-cash-spending-to-drop-33-this-year-says-goldman-4842621
5. https://insight.factset.com/sp-500-earnings-season-update-april-17-2020
6. On April 30, 2020 KPMG Quarterly Brief - Special Edition on Cost of Capital report.http://www.kpmg.at/NewsletterEvent/getFile.php?id=56442&hash=5ebd25e4e0c2e9.47097912
7. On April 16, 2020, Duff & Phelps held a webcast titled “Coronavirus: Cost of Capital Considerations in the Current Environment,”https://www.duffandphelps.com//media/assets/pdfs/publications/valuation/q2-valuation-insights-second-2020.pdf
8. On April 8, 2020 The Impact of Covid-19 on Valuations and Debt. https://www.bakermckenzie.com//media/files/insight/publications/2020/04/bloomberg-tax/baker mckenzie_bloomberg_the-impacts-of-covid19-on valuations-and-debt_4_8_20.pdf?la=en
9. On 26 May 2020. Marcus, B. The impact of the covid-19-crisis on business valuation. https://www.bdo.global/en-gb/blogs/valuations-blog/may-en/the-impact-of-the-covid-19-crisis-on-business-valuation
10. Gleißner, W. (forthcoming). Unternehmensbewertung in der „Corona-Krise“. CORPORATE FINANCE
11. Rabel, K. (2016). Grobplanungsphase und Terminal Value nach dem Standard KFS/BW1. RWZ
12. On April 29, 2020. Andrea A., Matthew S. Financial Impact Of COVID-19: Valuation Modifications. https://www.valentiam.com/newsandinsights/financial-impact-of-covid-19
13. On May 14, 2020. Tanvi P., COVID 19- The impact on Valuation. https://taxguru.in/finance/covid-19-impact-valuation.html
14. Assessing your Cost of Capital in a COVID-19 world. https://www.pwc.co.nz/issues/covid-19/pwc-cost-of-capital-in-the-current-climate.html
15. Bartl, M., & Gleißner, W. (2020). Unternehmensbewertung: Marktrisikoprämie in Österreich. CFOaktuell
16. Aders, C., Aschauer, E., & Dollinger, M. (2016). Die implizite Marktrisikoprämie am österreichischen Kapitalmarkt. RWZ
17. http://pages.stern.nyu.edu/~adamodar/
18. Adjusting for COVID-19 in valuations
19. Marcus, B. (2020) The impact of the covid-19-crisis on business valuation.
